M&T Bank Corp Sells 37,294 Shares of Corteva, Inc. $CTVA

M&T Bank Corp lowered its stake in shares of Corteva, Inc. (NYSE:CTVA) by 1.9% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,905,854 shares of the company’s stock after selling 37,294 shares during the period. M&T Bank Corp’s holdings in Corteva were worth $128,892,000 at the end of the most recent quarter.

Other institutional investors have also bought and sold shares of the company. Activest Wealth Management grew its holdings in Corteva by 118.3% during the third quarter. Activest Wealth Management now owns 369 shares of the company’s stock valued at $25,000 after purchasing an additional 200 shares during the period. True Wealth Design LLC raised its stake in shares of Corteva by 209.5% in the third quarter. True Wealth Design LLC now owns 390 shares of the company’s stock valued at $26,000 after buying an additional 264 shares during the period. Total Investment Management Inc. bought a new stake in shares of Corteva in the second quarter valued at $27,000. Twin Peaks Wealth Advisors LLC purchased a new position in shares of Corteva during the 2nd quarter valued at $29,000. Finally, Redmont Wealth Advisors LLC purchased a new position in shares of Corteva during the 3rd quarter valued at $29,000. Hedge funds and other institutional investors own 81.54% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages recently weighed in on CTVA. Wells Fargo & Company lifted their price objective on Corteva from $77.00 to $85.00 and gave the stock an “overweight” rating in a report on Thursday, February 5th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Corteva in a report on Monday, December 29th. Mizuho increased their target price on shares of Corteva from $80.00 to $82.00 and gave the stock an “outperform” rating in a research report on Tuesday, February 17th. Citigroup lifted their target price on shares of Corteva from $74.00 to $80.00 and gave the stock a “neutral” rating in a research note on Thursday, February 5th. Finally, UBS Group lowered shares of Corteva from a “buy” rating to a “hold” rating in a research report on Monday, February 9th. One investment analyst has rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and eight have issued a Hold rating to the company’s stock. Based on data from MarketBeat, Corteva has a consensus rating of “Moderate Buy” and a consensus price target of $82.90.

Insiders Place Their Bets

In other Corteva news, insider Brian Titus sold 8,311 shares of the stock in a transaction that occurred on Friday, February 20th. The shares were sold at an average price of $76.55, for a total value of $636,207.05. Following the sale, the insider directly owned 8,090 shares in the company, valued at $619,289.50. This represents a 50.67% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Company insiders own 0.14% of the company’s stock.

Corteva Stock Performance

Shares of CTVA opened at $79.13 on Friday. Corteva, Inc. has a 52-week low of $53.40 and a 52-week high of $80.90. The stock’s 50-day simple moving average is $74.11 and its 200 day simple moving average is $69.24. The company has a debt-to-equity ratio of 0.07, a quick ratio of 0.96 and a current ratio of 1.43. The stock has a market capitalization of $53.22 billion, a price-to-earnings ratio of 50.08, a price-to-earnings-growth ratio of 2.73 and a beta of 0.72.

Corteva (NYSE:CTVA) last posted its earnings results on Tuesday, February 3rd. The company reported $0.22 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.22. Corteva had a return on equity of 9.06% and a net margin of 6.29%.The business had revenue of $3.91 billion during the quarter, compared to analyst estimates of $4.23 billion. During the same quarter in the previous year, the firm earned $0.32 EPS. The company’s quarterly revenue was down 1.7% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Research analysts forecast that Corteva, Inc. will post 2.96 EPS for the current fiscal year.

Corteva Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, March 16th. Investors of record on Monday, March 2nd will be paid a dividend of $0.18 per share. The ex-dividend date of this dividend is Monday, March 2nd. This represents a $0.72 annualized dividend and a yield of 0.9%. Corteva’s payout ratio is currently 45.57%.

Corteva Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.